CCS is a fast growing biotechnology division under the New York Blood Center, and the prestigious choice to collaborate with for a wide range of clinical trial needs in the areas of regenerative medicine, cell therapies, transfusion medicine, and related endeavors.
Follow our blog for the latest news and insights from our experts to stay at the forefront of the industry.
Be The Match BioTherapies, recently named New York Blood Center a Center of Excellence
We are proud to congratulate Dr. Beth Shaz, Executive Vice President, Chief Medical and Scientific Officer of NYBC on being named one of Crain’s Notable Women in Healthcare.
Comprehensive Cell Solutions™ (CCS) leverages NYBC's strengths of innovation, flexibility, mobility, creativity, and quality.
At every step in the pipeline.
Stay at the forefront of the industry.
Don't see what you're looking for? Please ask!